With antimicrobial resistance on the rise, judicious selection of treatments is essential for optimizing patient outcomes. Our pharmacists specialize in interpreting resistance gene data and rely on the latest published research to guide the selection of appropriate antimicrobials.

Over 2.8 million infections in the United States are linked to antimicrobial resistance annually, resulting in more than 35,000 deaths

Antimicrobial resistance contributes to over $4.6 billion in healthcare costs each year, highlighting the economic burden of these infections.

Preventative efforts, including infection control and improved antimicrobial stewardship, have proven effective in reducing deaths caused by antimicrobial resistance